DEC 03, 2018 03:00 PM PST

Using bubbly nano-particles for chemotherapy delivery

We have all heard about the harsh side effects of chemotherapy that could be so difficult leading to stopping treatment. The reason behind those side effects is that chemotherapy drugs do target not only cancer cells but also the healthy cells of the body. So what if there was a way to solely target cancer cells without damaging normal cells.

Sofie, a Research Scientist at SINTEF’s Department of Biotechnology and Nanomedicine in Trondheim and a Postdoc at the Department of Physics at Norwegian University of Science and Technology (NTNU), is trying to achieve this by using nanoparticles and bubbles.

Her talk at the TEDx event was about her research on bubbly nanoparticles containing a chemotherapeutic drug, that when combined with ultrasound radiation at the target tissue, it creates a local force that disperses the nanoparticles to a broader area of cancer cells without affecting the rest of the body, which means fewer side effects and better treatment. The drug-loaded nanoparticles can be altered to when and where it will be degraded to evacuate the drug inside the cancer cells leading to its death.

This technology is promising also for brain diseases as nanoparticles can pass the blood-brain barrier into the brain cells leading to the possibility of using it with drugs for known diseases with no cure yet as Alzheimer's and Parkinson's.

Other research on the use of ultrasound with nanoparticles and the use of nanoparticles in cancer are also included.

Sources: Youtube, ScienceDirect, Hindawi

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
NOV 11, 2019
Cancer
NOV 11, 2019
Understanding TP53's role in cancer
New research published in the journal Cell Reports sheds light on the role of the TP53 gene in preventing the spread of cancer. The TP53 gene codes tumor p...
NOV 11, 2019
Cancer
NOV 11, 2019
Urine test detects cancer: watch out for blue pee!
New research from MIT engineers and Imperial and published in Nature Nanotechnology could change the way to detect cancer. The study highlights the develop...
NOV 11, 2019
Cancer
NOV 11, 2019
Infant with leukemia saved by liver cancer drug
A young child just months old recently successfully received cancer treatment for an uncommon type of leukemia. The drug used in the treatment was not a ta...
NOV 11, 2019
Drug Discovery & Development
NOV 11, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
NOV 11, 2019
Cell & Molecular Biology
NOV 11, 2019
Differences in Pediatric vs. Adult Cancer Force the Discussion of Effective Therapies
A team of scientists study the differences between childhood and adult cancer. This drives the discussion of the use of effective adult cancer treatments on children....
NOV 11, 2019
Cell & Molecular Biology
NOV 11, 2019
Discovery of Novel Biomarker for Lung Cancer Could Improve Survival
A molecular biomarker is discovered that improves diagnosing lung cancer and specializing treatment....
Loading Comments...